Its exciting to see Antara gaining Market share!!! We really are becoming "best in Class"
Anonymous Guest Anonymous   Jul 16, 2011 at 03:15: AM #1 Anonymous Guest Its exciting to see Antara gaining Market share!!! We really are becoming "best in Class"
Anonymous Guest Anonymous   Jul 16, 2011 at 01:12: PM #2 Anonymous Guest Anonymous said: Its exciting to see Antara gaining Market share!!! We really are becoming "best in Class" Click to expand... BS! PDI is promoting Fenoglide for Shore Therapeutics and is gaining market share.
Anonymous said: Its exciting to see Antara gaining Market share!!! We really are becoming "best in Class" Click to expand... BS! PDI is promoting Fenoglide for Shore Therapeutics and is gaining market share.
Anonymous Guest Anonymous   Jul 17, 2011 at 08:37: AM #3 Anonymous Guest LIPOFEN is kicking our ass!
Anonymous Guest Anonymous   Jul 18, 2011 at 09:24: PM #4 Anonymous Guest obviously youre kidding. the 6,000 TRX a week have seen a steady decline for around 2 years. There is no place for any feno, especially ANTARA. I actuallly think what lupin is doing is a joke.
obviously youre kidding. the 6,000 TRX a week have seen a steady decline for around 2 years. There is no place for any feno, especially ANTARA. I actuallly think what lupin is doing is a joke.
Anonymous Guest Anonymous   Jul 27, 2011 at 08:22: PM #5 Anonymous Guest Antara is a great product, period. The new Visual aid is a "Game Changer", Abbott & Kowa are on their heals!!
Antara is a great product, period. The new Visual aid is a "Game Changer", Abbott & Kowa are on their heals!!
Anonymous Guest Anonymous   Jul 29, 2011 at 02:35: AM #6 Anonymous Guest You morons, join abbot and kowa loosers, no room for a feno u cack. Yes period! Generic feno rules dick head
You morons, join abbot and kowa loosers, no room for a feno u cack. Yes period! Generic feno rules dick head
Anonymous Guest Anonymous   Sep 08, 2011 at 08:07: PM #7 Anonymous Guest Dude learn to spell...it's Abbott and dickhead.
Anonymous Guest Anonymous   Oct 30, 2011 at 05:24: PM #8 Anonymous Guest Anonymous said: Its exciting to see Antara gaining Market share!!! We really are becoming "best in Class" Click to expand... And the class is junk! No outcomes, no data. It's sad to think the only fibrate with data behind it (VA-HIT) is gemfibrozil.
Anonymous said: Its exciting to see Antara gaining Market share!!! We really are becoming "best in Class" Click to expand... And the class is junk! No outcomes, no data. It's sad to think the only fibrate with data behind it (VA-HIT) is gemfibrozil.
Anonymous Guest Anonymous   Oct 30, 2011 at 05:26: PM #9 Anonymous Guest Anonymous said: And the class is junk! No outcomes, no data. It's sad to think the only fibrate with data behind it (VA-HIT) is gemfibrozil. Click to expand... And Every fenofibe is either Trilipix, TriCor, or an older version of TriCor.
Anonymous said: And the class is junk! No outcomes, no data. It's sad to think the only fibrate with data behind it (VA-HIT) is gemfibrozil. Click to expand... And Every fenofibe is either Trilipix, TriCor, or an older version of TriCor.